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Contraception has profound benefits for women and society, 
including reduced maternal and infant mortality and morbidity, 
empowerment of women to make informed choices about fertility, 
economic advancement, and a reduction in the number of children 
infected with HIV.[1,2] In recent decades, contraceptive use has 
risen markedly worldwide, although at a much slower pace in 
sub-Saharan Africa than elsewhere.[3] About a quarter of women in 
sub-Saharan Africa currently use modern contraceptive methods, 
with levels highest in southern Africa.[4,5] In South Africa (SA), for 
example, estimates of the proportion of women of reproductive age 
who are protected against unplanned pregnancies, using modern 
contraceptive methods, have increased steadily from 26.3% in 
2002/2003 to 37.3% in 2013/2014.[6] These figures are drawn from a 
district health information system covering the public sector, while 
population level end-user data have yielded somewhat different 
estimates. For example, the 2003 Demographic and Health Survey,[7] 
the most recent available national report, found a contraceptive 
prevalence of 64.7%, similar to more recent modelling estimates.[8] 
Regardless of which figures are correct, the continued rise in the 
number of terminations of pregnancy in SA among all age groups 
suggests that substantial deficiencies remain in accessing family 
planning services.[6]  
Increasing the range of contraception choices available is a key 
component of ensuring access for women, their partners and couples 
to the most effective method they wish to use. Global policymakers 
and policy advocates have placed particular emphasis on increasing 
access to long-acting reversible contraception (LARC) methods, 
including intrauterine devices and subdermal implants. These are 
highly effective, and markedly diminish the need for user adherence 
and contact with health workers. Many providers in SA are, however, 
still unfamiliar with these methods.[9-11] In SA, as throughout sub-
Saharan Africa, the injectable progestins depot-medroxyprogesterone 
acetate (DMPA) and norethisterone enanthate (NET-EN) are the 
most popular contraceptive methods,[4] and their use has continued 
to rise over time.[12] Nationally, about 5.8 million doses of DMPA are 
administered annually.[6] By contrast, in most high-income countries, 
use of injectable contraceptives is rare, aside from in marginalised 
groups, such as poor, African American or aboriginal women.[13-16] 
The popularity of injectables in sub-Saharan Africa is ascribed to 
its convenience for providers and women, cost effectiveness, and 
high acceptability among women and health providers.[2] Method 
discontinuation and contraceptive failure, however, frequently occur 
with this method.[17,18] 
Using data from the 2012 SA National HIV Prevalence, Incidence 
and Behaviour Survey,[19] this analysis assesses the extent of unmet 
contraceptive need, and estimates the overall contraception coverage 
and methods used. We also aimed to identify underserved populations 
through examining the demographic factors and sexual behaviours 
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associated with contraceptive use. In addition to providing updated 
figures on key family planning indicators, the study seeks to identify 
the areas that need to be addressed to strengthen family planning 
services in SA and similar settings. 
Methods
Survey sampling, field and laboratory procedures
The fourth SA National HIV Prevalence, Incidence and Behaviour 
Survey[19] took place from January to November 2012. This popu-
lation-based survey applied multistage stratified sampling by prov-
ince; locality (urban formal, urban informal, rural formal including 
commercial farms, and rural informal or tribal authority areas); and 
predominant racial groups. Sampling frames were based on enumera-
tor areas (EA) used in the national census, updated in 2007 to reflect 
changes in the sociodemographic profile of the country since 2001. 
In total, 1 000 EAs were selected from a database of 86 000 EAs as the 
primary sampling units, 15 households within each EA constituted 
the secondary sampling unit (15 000 households), and all persons 
in the selected households were eligible for the survey. Additional 
details of the survey methodology, including fieldwork procedures 
and quality control measures, are described elsewhere.[19] 
Dried blood spot specimens collected by finger prick were tested 
in a laboratory for HIV antibodies using a testing algorithm with 
three different immunoassays. All HIV testing was anonymous 
and unlinked to personal identifiers. Individuals were given an 
opportunity to access their HIV test results 8 weeks after testing at 
designated facilities, using bar codes to preserve anonymity. The 
study protocol was approved by the Human Sciences Research 
Council’s Research Ethics Committee (ref. no. 5/17/11/10) and the 
Human Subjects Review from the Centers for Disease Control 
and Prevention’s Global AIDS Programme. Only women in the 
reproductive age group (15 - 49 years) who had ever had sex were 
included in this analysis.
Study measures
Data were drawn from face-to-face questionnaires, which elicited 
detailed information on demographic and socioeconomic character-
istics, contraception use, sexual behaviours and other risk factors for 
HIV infection. In a multiple-response question, women were asked if 
they ever had used or were currently using a contraceptive method, 
specifically injectable or oral contraception, an intrauterine device 
(IUD), female or male sterilisation, or natural family planning. In a 
separate question, women reported condom use at last sex and con-
sistent condom use with their last partner. Injectable contraception 
referred to the use of either DMPA or NET-EN, as women were not 
asked to differentiate between these methods.
Contraceptive prevalence was defined as the percentage of women 
aged 15 - 49 years, who were using (or whose partner was using) a 
contraceptive method at the time of the interview.[20] Contraceptive 
methods consisted of injectable and oral hormones, IUDs, female 
and male sterilisation, emergency contraception, and other (consis-
tent condom use with last partner, natural family planning, or with-
drawal). The indicator only includes women who were sexually active 
(had sex in previous 12 months), and not pregnant or amenorrhoeic. 
Injectable and oral hormones, IUDs, and female or male sterilisation 
were considered modern contraception. Condoms were excluded 
from this definition as biases inherent in its measurement may both 
under- and overestimate its use for contraception, hampering inter-
pretation.[21] We used unintended pregnancy as a proxy indicator of 
unmet need for contraception. 
Socioeconomic quartiles were derived from measures of house-
hold living standards captured in the household questionnaire: 
infrastructure and housing characteristics (source of drinking water, 
access to electricity, main source of energy for cooking and type of 
toilet used) and household ownership of durable assets (presence of a 
working refrigerator, radio, television, cellphone and landline phone). 
Details of how quartiles were generated and the rationale for using 
quartiles, rather than the commonly used quintiles, are provided 
elsewhere.[22,23] 
Data management and analysis
After double data entry, data validity was verified using the Census and 
Survey Processing System (CSPro) (US Census Bureau, USA).[24] Data 
were analysed using Stata version 14.0 (Stata Corporation, USA), taking 
into account the complex multilevel sampling design (by age, race group 
and province) and participant non-response. Summary indices for 
descriptive analysis are weighted percentages, and unweighted counts 
are provided. 
Descriptive analyses were conducted to investigate whether use of 
any contraception or individual method was associated with demo-
graphic, social or economic characteristics, or pregnancy history. We 
also determined whether sexual behaviour, condom use, HIV risk 
perception and HIV status varied between women using different 
contraceptive methods. In descriptive and bivariate analyses, asso-
ciations were identified using the Rao-Scott F statistic to determine 
p-values. 
Results
Unmet need for contraception
Among the 8 482 women aged 15 - 49 years who had ever had sex, 
81.1% reported being sexually active in the past year (Table 1). These 
figures were lowest among women 35 - 49 years (75.1%) compared 
with 83.0% in those 15 - 19 years, and about 85% among the other 
age groups (p<0.001). Age was also associated with unintended 
pregnancy among the 3 538 women who reported a pregnancy in 
the past 5 years. Overall, a third of these women (33.5%) had desired 
to become pregnant at the time of their last pregnancy; this was 
reported by only 10.1% of women 15 - 19 years of age and 20.9% of 
those 20 - 24 years of age (p<0.001). At the time of the pregnancy, 
about half of women 15 - 19 years (51.2%) and 20 - 24 years (48.5%) 
had not wanted to have a child. In older women, these levels were 
41.3% for women 25 - 34 years and 44.9% for those 35 - 49 years. 
Among the 276 women who were pregnant at the time of the survey, 
only half (50.6%) had wanted to become pregnant. About a quarter 
(24.0%) of all women who reported a pregnancy in the past 5 years 
had been using a contraceptive method at the time of their pregnancy. 
These levels were only 12.8% in 15 - 19-year-olds compared with 
19.7% in 20 - 24-year olds and 26.1% in women ≥25 years (p<0.01). 
Contraceptive knowledge and prevalence 
Of women who had ever had sex, almost all (92.0%) were aware of 
injectable contraception, with similarly high levels of knowledge of 
oral contraception (89.9%) and female sterilisation (73.3%; Table 2). 
Only about half, however, had heard of IUDs, emergency contracep-
tion or male sterilisation (56.1%, 47.3%, and 45.3%, respectively). 
Levels of knowledge among women aged 15 - 19 years were lower 
than those of older women for each contraceptive method. Most 
notably, only 30.9% of 15 - 19-year-olds knew of IUDs and 36.2% of 
emergency contraception, considerably lower than for other women. 
On average, women had heard of 4 - 5 contraceptive methods in total. 
Just under half of the 8 245 women responding to questions about 
lifetime contraception use (women who had ever had sex) reported 
having ever used injectable contraception (46.2%) and a quarter had 
ever used oral contraception (25.6%). Aside from the ‘other contra-
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ceptive’ category, ever use of all other methods (IUD, female sterili-
sation, male sterilisation, and emergency contraception) was <10%. 
Overall, current contraceptive prevalence was 49.1%, and 41.8% 
of women were using modern, non-barrier methods (Table 3). 
Injectable contraception was by far the most common method, used 
by 25.0% of women. Other methods were several-fold less common 
and only a negligible portion were using an IUD (1.6%). Among 
injectable contraception users, the majority had obtained this method 
of contraception at a clinic or community health centre (70.8%), 
while other methods were much less likely to have been provided 
at these facilities (<50% for all). A notably higher proportion of oral 
and emergency contraception users, and female and male sterilisation 
users, acquired their contraception from a private facility or doctor 
(23.0%, 21.3%, 26.5% and 41.5% respectively), while a considerable 
proportion of IUDs were obtained from a pharmacy (27.3%).
Sociodemographic factors and contraception use
Table 3 shows the distribution of contraceptive methods among the 
6 296 sexually active women, stratified by sociodemographic groups. 
Only about a third of women aged 15 - 19 years were using modern 
contraception, only 5.0% were using oral contraception, and 0.4% an 
IUD. Compared with their younger counterparts, more women aged 
20 - 34 or 35 - 49 years were using modern contraception (42.7% and 
41.8%, respectively). A considerable proportion of women 35 - 49 years 
old had been sterilised (16.4%), but their use of injectables (16.2%) 
was much lower than that of women aged 15 - 19 years (26.1%) and 
those 20 - 34 years (30.5%). 
Contraceptive coverage was highest in the Western Cape (54.0%), 
Eastern Cape (50.7%) and KwaZulu-Natal (50.1%), and lowest in 
the Northern Cape (42.2%) and Mpumalanga (45.0%). Prevalence 
of any contraceptive use differed by race, ranging from 47.2% in 
black Africans, 52.4% in coloureds, 61.1% in Indians/Asians, to 
61.9% in whites (p<0.001). While 27.5% of black African and 23.8% 
of coloured women were using injectables, the method is only used 
by 6.8% of Indians/Asians, and 4.8% of whites (p<0.001). Oral 
contraception, on the other hand, was more likely to be reported 
by white and Indian/Asian women (22.8% and 22.5%, respectively). 
IUDs were also relatively more common among whites (6.0%) and 
Indians/Asians (3.8%). Female sterilisation among Indian/Asian 
Table 1. Indices of unmet need for contraception in different 
age groups, SA, 2012
Variable Prevalence p-value
Sexually active past 6 months, 
age (years)*
15 - 19 (n=659)
20 - 24 (n=1 489)
25 - 34 (n=2 772)
35 - 49 (n=3 576)
83.0
84.6
85.7
75.1 <0.001
Currently pregnant, age (years)†
15 - 19 (n=500)
20 - 24 (n=1 197)
25 - 34 (n=2 235)
35 - 49 (n=2 587)
6.6
6.1
8.1
1.7 <0.001
Intended to become pregnant, 
age (years)‡
15 - 19 (n=216)
20 - 24 (n=805)
25 - 34 (n=1 613)
35 - 49 (n=904)
10.1
20.9
37.4
42.1 <0.001
Did not want to have a child, 
age (years)‡
15 - 19 (n=216)
20 - 24 (n=805)
25 - 34 (n=1 613)
35 - 49 (n=904)
51.2
48.5
41.3
44.9 <0.001
Used contraception at time of 
pregnancy, age (years)‡
15 - 19 (n=214)
20 - 24 (n=800)
25 - 34 (n=1 610)
35 - 49 (n=906)
12.8
19.7
26.1
26.1 <0.01
*Among women who had ever had sex (n=8 482).
†Among sexually active women.
‡Among women who were pregnant in past 5 years.
Table 2. Contraceptive method awareness, prevalence and access point of SA women, 2012
Variable (unweighted n)
Injectable con-
traception, %
Oral con-
traception, % IUD, %
Female 
sterilisation, %
Male 
sterilisation, %
Emergency con-
traception, %
Other, 
%†
Knows of method (n=8 507) 92.0 89.9 56.1 73.3 45.3 47.3 61.8
Ever used method (n=8 245) 46.2 25.6 4.5 8.2 1.9 5.7 18.7
Currently used method (n=6 296)* 25.0 8.6 1.6 8.1 2.3 0.8 11.4
Where obtained method              
Hospital (n=567) 10.2 8.3 8.4 34.8 25.6 19.7 9.1
Clinic or CHC (n=1 935) 70.8 42.3 48.5 24.0 19.9 40.6 48.9
Mobile clinic (n=124) 3.5 1.9 1.5 1.0 0.1 7.3 0.8
Family planning clinic  (n=345) 8.3 10.9 3.6 4.5 1.2 1.5 4.3
Private facility (n=177)  1.1 1.0 2.9 23.5 38.7 0.0 2.1
Private doctor (n=283) 1.9 22.0 5.3 3.0 2.8 21.3 14.0
Pharmacy (n=179) 2.3 10.7 27.3 2.6 6.6 0.5 3.6
Other (n=332) 1.8 2.7 2.4 6.7 5.0 9.2 17.2
CHC = community health centre.
*Among those who reported sexual activity in the past year. 
†Consistent condom use with last partner, natural family planning or withdrawal. 
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women (27.9%) was considerably more frequent than in other races, 
while 16.6% of white women had been sterilised, as had 13.0% of 
their male partners. 
Compared with the poorest quartile, women in the two highest 
socioeconomic quartiles were much less likely to use injectable hor-
monal contraceptives (for QIII: odds ratio (OR) 0.60, 95% confidence 
interval (CI) 0.46 - 0.78; and for QIV: OR 0.30, 95% CI 0.22 - 0.41). 
However, the opposite associations were observed with all other 
contraceptive methods, higher socioeconomic quartiles being associ-
ated with increased odds of contraceptive use. Associations between 
educational level and contraceptive method mirrored those of socio-
economic status (SES). For example, the method mix for women with 
tertiary education differed considerably from others: 14.5% were 
using oral contraception and 2.4% had used emergency contracep-
tion – much higher than in other groups. 
Women’s sexual behaviour and HIV risk by type of 
contraception
Table 4 shows the distribution of sexual behaviour by contraceptive 
method. Overall, of all sexually active women, most reported ≤3 lifetime 
sexual partners (75.0%), and only 5.3% had had >1 partner over the past 
year. Close to 40.0% of participants mentioned having had age-disparate 
sex partners (partners ≥5 years older than the woman). About a third 
used a condom at last sex (38.5%) and reported consistent condom 
Table 3. Demographic characteristics of current contraceptive users among sexually active women, SA, 2012
Variable  
(unweighted n)
Any 
method, %
Modern 
method, %†
Injectable 
method, % 
Oral con-
traception, % IUD, %
Female steri-
lisation, % 
Male sterili-
sation, % 
Emer -
gen cy, %
Others, 
%
Not 
using, % 
Total (n=6 296) 49.1 41.8 25.0 8.6 1.6 8.1 2.3 0.9 11.4 50.9
Age (years)     *** *** **      
15 - 19 (n=490) 43.7 34.1 26.1 5.0 0.4 3.6 2.2 0.6 12.5 56.3
20 - 34 (n=3 362) 50.3 42.7 30.5 9.3 1.5 3.5 1.1 1.0 11.7 49.7
35 - 49 (n=2 444) 48.3 41.8 16.2 8.4 1.9 16.4 4.3 0.6 10.7 51.7
Race ***   *** *** *** *** ***   * ***
Black African (n=3 982) 47.2 39.7 27.5 6.8 1.1 6.3 1.3 0.9 11.8 52.8
White (n=512) 61.9 51.3 4.8 22.8 6.0 16.6 13.0 1.4 14.8 38.1
Coloured (n=1 122) 52.4 47.6 23.8 9.7 1.9 12.3 2.8 0.2 7.0 47.6
Indian/Asian (n=670) 61.1 58.3 6.8 22.5 3.8 27.9 1.4 0.2 5.3 38.9
Province     *** **   *** ** * ***  
Western Cape (n=820) 54.0 49.3 23.8 7.2 2.6 15.6 5.5 0.1 8.5 46.0
Eastern Cape (n=725) 50.7 43.4 34.6 3.4 0.9 5.7 0.6 0.8 10.1 49.3
Northern Cape (n=480) 42.2 39.5 24.8 7.1 1.7 6.0 2.7 0.0 4.3 57.8
Free State (n=459) 52.6 44.2 29.7 12.0 3.1 7.0 1.5 3.2 15.8 47.4
KwaZulu-Natal (n=1 499) 50.1 45.8 32.5 7.2 1.4 5.8 1.1 0.5 6.2 49.9
North West (n=460) 46.3 35.1 21.2 7.7 1.1 6.7 0.8 0.5 14.4 53.7
Gauteng (n=876) 48.1 39.0 18.4 11.1 1.7 9.7 3.3 0.9 13.1 51.9
Mpumalanga (n=470) 45.0 38.8 21.2 11.8 0.7 6.2 3.4 1.7 13.3 55.0
Limpopo (n=507) 46.3 34.9 21.3 9.1 1.1 5.9 0.6 0.7 18.4 53.7
Education status     *** *** * *    
Grade 0 - 3 (n=112) 37.3 33.2 23.8 4.8 2.2 6.4 0.0 0.3 8.5 62.7
Grade 4 - 7 (n=576) 44.0 37.6 28.6 3.6 0.4 7.1 0.8 0.9 8.8 56.0
Grade 8 - 11 (n=2 207) 51.0 44.8 30.2 6.8 1.4 8.4 1.7 0.8 11.3 49.0
Grade 12 (n=2 149) 49.8 41.2 24.1 10.5 1.3 7.1 2.0 0.5 12.5 50.2
Tertiary (n=611) 53.3 43.2 14.9 14.5 3.4 11.2 4.2 2.4 12.8 46.7
Socioeconomic status     *** *** ** *** ***      
Quartile 1 (n=1 204) 48.2 41.7 33.2 5.7 1.0 4.4 0.2 0.6 10.5 51.8
Quartile 2 (n=1 300) 48.3 40.5 30.4 5.6 1.1 5.2 0.8 0.5 11.7 51.7
Quartile 3 (n=1 953) 47.5 40.0 23.1 9.6 1.2 8.7 2.3 1.0 12.3 52.5
Quartile 4 (n=1 763) 53.7 46.0 12.9 13.9 3.4 15.7 6.1 1.3 10.8 46.3
Ever pregnant (n=5 049) 52.1*** 45.3 26.8*** 8.9 1.5 9.5*** 2.4 0.7 11.0 47.9***
Sexually active = sex in past year.
*p=0.01 - 0.05, **p=0.01 - 0.001, ***p<0.001. 
†Injectable contraception, oral contraception, IUD or sterilisation.
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use (30.4%). Sexual behaviours among women using injectables were 
broadly similar to those of other women. For oral contraceptive users, 
however, 11.0% of whites reported consistent condom use compared 
with 25.1% of black Africans. These patterns were similar in women 
who had been sterilised (11.7% of white women reporting consistent 
condom use compared with 26.7% of black African women). Those not 
using any method of contraception were more likely to have multiple 
sexual partners in the past year (6.1%) than other women, but otherwise 
had similar behaviours as contraceptive users. Younger women (aged 
15 - 19 years) who used modern contraception were less likely to 
report multiple sexual partners in the past year than non-users (4.2% 
among users v. 8.0% among non-users, p=0.002). However, those using 
contraception had lower levels of consistent condom use than other 
youth (23.6% v. 38.9%, p<0.001).
One-third of sexually active women perceived themselves to be at 
high risk of HIV infection (34.6%). Perceptions of risk for HIV varied 
by race and contraceptive method. Perceptions of high risk were 
markedly higher among black Africans than other race groups. Some 
46.2% of black African women currently using injectables felt they 
were at high risk for HIV infection, higher than levels among black 
Africans using oral contraceptives (38.6%) and sterilisation (30.7%), or 
those not using any methods (38.3%). Less than 5% of white, coloured 
or Indian/Asian women perceived themselves at risk for HIV, with 
similar levels between women using different contraceptive methods. 
Interestingly, perceptions of HIV risk were high among women who 
used emergency contraception (43.1%), but they also reported high 
levels of consistent condom use (47.2%). HIV-positive women were 
less likely than HIV-negative women to use oral contraception, IUDs 
or to have been sterilised. Use of injectables did not vary by HIV status.
Discussion
In this national survey of women, about 41.0% were using modern 
contraception. Gradual increments have been made in contraception 
prevalence over time in SA, although the rate of increase appears 
Table 4. Sexual behaviour and HIV status by current contraceptive use among sexually active women in SA, 2012
Variable  
(unweighted n)
Total 
popula-
tion, %
Injectable 
method, 
%
Oral 
contra-
ception, % IUD, %
Female 
sterili-
sation, % 
Male 
sterili-
sation, % 
Emergency, 
%
Others, 
%
Not 
using, 
% 
Lifetime sexual partners, n             ** **  
1 (n=2 162) 31.9 31.5 35.2 33.3 38.3 34.9 26.3 23.9 30.9
2 - 3 (n=2 495) 43.1 45.0 36.5 29.1 40.5 38.5 28.1 43.8 43.1
4 - 6 (n=2 495) 20.3 20.1 23.2 27.1 17.9 26.0 45.1 23.5 21.0
≥7 (n=279) 4.6 3.3 5.1 10.6 3.3 0.6 0.4 8.9 4.9
Partners in past year, n               ** *
1 (n=5 961) 94.7 95.3 96.4 97.3 95.9 94.9 92.5 91.7 93.9
≥2 (n=298) 5.3 4.7 3.6 2.7 4.1 5.1 7.5 8.3 6.1
Concurrent partners†                  
No (n=80) 56.1 58.2 82.4 39.7 48.6 0.0 51.4 59.7 56.0
Yes (n=75) 43.9 41.8 17.6 60.3 51.4 100 48.6 40.3 44.0
Intergenerational sex         ** *   *  
No (n=3 885) 60.4 59.9 64.0 69.8 49.0 42.8 56.7 66.1 60.4
Yes (n=2 321) 39.6 40.1 36.0 30.2 51.0 57.2 43.3 33.9 39.6
Condom use at last sex                  
No (n=4 066) 61.5 63.8 67.5 70.9 76.7 81.3 47.3 34.4 60.1
Yes (n=2 094) 38.5 36.2 32.5 29.1 23.3 18.7 52.7 65.6 39.9
Consistency of condom use     ***   **     *** *
Inconsistent or none  
    (n=4 519)
69.6 72.5 80.2 76.3 80.8 77.0 52.8 50.5 67.3
Yes (n=1 687) 30.4 27.5 19.8 23.7 19.2 23.0 47.2 49.5 32.7
Perceived risk of HIV 
infection
  *** **   *** **   *  
Low risk (n=4 425) 65.4 57.2 74.1 71.4 79.8 87.7 56.9 59.4 66.5
High risk (n=1 820) 34.6 42.8 25.9 28.6 20.2 12.3 43.1 40.6 33.5
HIV status     * ** **        
Negative (n=3 968) 73.3 72.2 80.6 89.6 83.3 82.6 78.1 71.1 71.6
Positive (n=1 083) 26.7 27.8 19.4 10.4 16.7 17.4 21.9 28.9 28.4
Sexually active = sex in past year.
*p=0.01 - 0.05, **p=0.01 - 0.001, ***p<0.001.
†Among those with multiple sexual partners in past year. 
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to be slowing. Consistent with rises in contraception use, the total 
fertility rate has declined gradually, from 2.7 children per woman in 
2002 to 2.3 in 2013.[25] The fastest rate of change in fertility occurred 
in the Eastern Cape and KwaZulu-Natal, provinces with among the 
highest levels of contraceptive prevalence in this study. Of note, we 
found that about two-thirds of all pregnancies were unintended, 
similar to levels reported in several smaller studies.[26-28] The rate 
of unintended pregnancy was even higher in young women, who 
commonly experience stigma and economic difficulties during 
pregnancy,[29] and especially high levels of maternal morbidity and 
mortality.[30-32] 
Low levels of knowledge and frequent misconceptions about contra-
ception among women of 15 - 19 years are particularly concerning.[33,34] 
These findings cast doubt on how effectively the national Integrated 
School Health Policy[35,36] is being implemented. The policy recom-
mends that school health services act as a delivery platform for the 
provision of sexual and reproductive health services, such as contra-
ception and condom distribution.[37] Legally, anyone aged ≥12 years 
has the right to receive contraception without parental consent.[38] The 
provision of contraception in schools, however, requires the explicit 
permission of individual school-governing bodies – few have, however, 
given permission.[39] When contraception services are made available, 
school-based services will need to be carefully designed to counter 
adolescents’ concerns around privacy,[35] as also noted in studies of 
HIV testing in schools.[40] Youth-friendly services in community-based 
primary care facilities are another important option for improving ado-
lescent access to contraception. Over the past two decades, many initia-
tives have been made in this direction in SA.[36,41] These programmes 
reached high coverage and performed well against predefined stan-
dards relating to services provided and clinical environment.[42,43] In 
recent years, however, several reports have noted weaknesses in these 
programmes and the need for strengthening of these services.[36,43,44] 
In the public sector, more broadly, supply-side barriers include 
strong provider preferences for particular methods, lengthy waits at 
clinic services, and staff with negative attitudes, e.g. towards young 
women requesting contraception or an abortion.[45] Although, overall, 
women largely make use of the public sector for healthcare,[46] a large 
proportion of women in our study turned to private sector doctors 
or pharmacists, where they are offered a wider mix of methods. 
This suggests that the government’s policy, that women requesting 
contraception should receive the method of their choice, has not been 
fully actualised, especially in primary health clinics and community 
centres. Contraception use and method type are strongly associated 
with race in this study and also with SES at an individual and 
geographical level. Marked differentials between poor and wealthy 
districts were noted in other studies.[47-49] All the abovementioned 
reasons relating to age and SES mean that younger poorer women 
are particularly vulnerable to unintended pregnancies, and much 
remains to be done to mitigate their risk.[33,49,50] 
The National Contraception and Fertility Planning Policy and Service 
Delivery Guidelines[51] in 2012 marked an important step away from 
methods requiring users’ adherence, and placed particular emphasis on 
LARC methods, aiming to raise choice and contraceptive effectiveness (a 
quarter of women who had a pregnancy reported contraceptive failure 
in our study). The guidelines state that clients should have access to 
‘accurate, unbiased information about all available methods to make an 
informed choice’. In practice, what is available in primary level facilities 
varies and coverage of services for sterilisation, and even IUD insertion, 
is extremely limited in some districts.[36] Facilities such as those for HIV 
treatment seldom offer contraceptive services. Ensuring adequate stocks 
of the wide range of contraceptive methods is contingent on accurate 
forecasting of the demand for each method. This is difficult to achieve, 
given the limited data available in the public sector to predict the 
anticipated demand, especially for new methods.[36] 
With injectable contraception, which comprises three-quarters of 
the modern methods used, method discontinuation, timeliness of 
repeat injections, and switching remain key contributors to contracep-
tion failures in SA.[17,18,21] Up to half of women in a study in the Eastern 
and Western Cape were late for their re-injection appointment.[18] 
Women, however, have limited knowledge of and experience with the 
‘newer’ contraceptive methods.[26,33,34,52,53] Only half of our participants 
had heard of emergency contraception, the same portion as a study 
among female university students in 2011,[54] but higher than the 30.0% 
knowledge found in a Cape Town study of women in public sector 
clinics in 2004/2005.[53] Clearly, the introduction of LARCs and future 
multipurpose technologies will require intensive awareness campaigns, 
encompassing efforts to address health worker misperceptions of 
these technologies.[10,11] Encouragingly, despite these problems, uptake 
of sub-dermal implants, rolled out in 2014 in SA and accompanied 
by substantial promotion efforts, has been encouraging.[55] Training 
manuals covering implant insertion were developed and >6 000 pro-
viders were trained, mainly nurses. While as many as 800 000 devices 
had been inserted by the end of 2014,[56] the delivery of the method has 
been hampered by poor data for monitoring adverse effects, such as 
early removal of the device, and poor communication by the National 
Department of Health around concerns of drug interactions between 
the antiretroviral drug efavirenz and the synthetic progesterones in the 
implant.[36]
Injectable contraception, particularly DMPA, has been associated 
with an increased risk of HIV acquisition in some, but not all, studies.[57,58] 
Overall, systematic reviews and an individual patient data meta-analysis 
suggest about a 1.5-fold increased risk of HIV acquisition with 
DMPA exposure,[59,60] but many studies included in these reviews 
have important methodological flaws.[61] After many years of calls 
for a randomised controlled trial to deeply examine this relationship, 
a trial will commence shortly.[62,63] Until further data are available, 
it is likely that the benefits of discouraging DMPA use would be 
outweighed by the risks of unwanted pregnancy and maternal deaths. 
This is especially true of countries such as Madagascar, with high 
maternal mortality risks,[64] but perhaps less so in SA. 
In our study, HIV-positive women were less likely than HIV-
negative women to use oral contraception and IUDs. Some evidence 
indicates that many health workers hold misconceptions about 
interactions between contraception and antiretroviral treatment, 
and offer HIV-positive women different contraceptives than other 
women.[10,26,65-68] Other studies, however, have found that HIV-
positive and HIV-negative women have a similar methods mix 
and fertility goals.[26,65,68-70] Integration of family planning within 
services for antiretroviral treatment and for prevention of mother-
to-child transmission holds much promise in raising contraceptive 
prevalence among HIV-positive women,[1,27,71] although it is not 
without challenges.[72] 
Study limitations
This article provides population-level representative data for the 
country, a uniquely important dataset. However, cross-sectional studies 
such as this one do not allow for observation of temporal relation-
ships. This study cannot ascertain which contraceptive method was 
used at the time of HIV acquisition and thus cannot investigate causal 
associations between HIV infection and contraception method, for 
example. Additional limitations include a reliance on self-reporting 
of contraceptive use. It was therefore not possible to assess methods 
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dispensed, but not actually used, or used incorrectly (especially 
user-dependent methods such as oral contraception and condoms).[73] 
Finally, while the study provides some measure of unmet need for 
contraception, this indicator is hard to measure, and the variable 
used (unintended pregnancy) only provides limited information.[74,75] 
Conclusion
Even though levels appear to be rising slowly over time, less than 
half of SA women were using a modern contraceptive method in 
2012. Women with only primary school education and of lower 
SES were less likely to report contraceptive use. In light of high 
unintended pregnancy rates and contraceptive failure noted in this 
study, it is hoped that SA’s new contraceptive policy and clinical 
guidelines[51,76] will be fully implemented as a national health priority. 
Additional emphasis on access to LARCs, particularly among women 
in poorer provinces and with lower SES, is necessary in the coming 
years to further improve the SA family planning services. Until 
then, injectable contraception remains an important contraceptive 
method for women in this country, particularly for black African 
women and those with lower SES, who do not yet have access to 
a range of methods. In common with other countries,[77] young 
women had low contraception use and poorer levels of knowledge 
about these methods, making it clear that the reproductive health 
component of the School Health Programme needs to be considerably 
strengthened. It is very disappointing that many young women leave 
school with little knowledge of contraception. In summary, access to 
contraception and choice of a range of methods are key interventions 
to improve population health, particularly that of women. Increased 
political and economic investment is necessary to decrease disparities 
in access to contraception between population groups and to raise 
overall levels of contraception.
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